Finch Therapeutics Group, Inc.
- FNCH
- OTC
- Biotechnology
- Microbiome Therapeutics
- Biotech IP/Licensing
$10.20
Today +0.99%Quote Aug 5, 2026, 07:47 PM UTC
+27.53%over the last month
Max drawdown −9.9%From 1-month high −5.2%3 months −21.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Finch Therapeutics
Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. The company is now focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations after winding down development efforts.
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Employees
1
Market value
$16.4M
Quote Aug 5
Analyst target
$159.98
+1468.4% from here
Floor
$10.15
0.5% below price
Resistance
$10.29
0.9% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about FNCHPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free